| Q38993921 | A microarray MEMS device for biolistic delivery of vaccine and drug powders |
| Q34254990 | AHAPS-functionalized silica nanoparticles do not modulate allergic contact dermatitis in mice |
| Q37792508 | Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? |
| Q38285751 | Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology |
| Q34540809 | Canine recombinant adenovirus vector induces an immunogenicity-related gene expression profile in skin-migrated CD11b⁺ -type DCs. |
| Q37524050 | Chitosan-based systems for the delivery of vaccine antigens |
| Q42244601 | Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery |
| Q37958512 | Devices for intradermal vaccination |
| Q47973670 | Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal |
| Q37521185 | Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model |
| Q43310856 | Immunization via the anal mucosa and adjacent skin to protect against respiratory virus infections and allergic rhinitis: a hypothesis |
| Q57492118 | Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy |
| Q41731948 | Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses. |
| Q33963746 | Malaria vaccine development and how external forces shape it: an overview |
| Q38066148 | Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective |
| Q34059945 | Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations |
| Q38418305 | Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine. |
| Q50610735 | Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. |
| Q26825418 | Nanoparticulate adjuvants and delivery systems for allergen immunotherapy |
| Q84746474 | New emerging technologies and the intradermal route: the novel way to immunize against influenza |
| Q51839589 | Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. |
| Q33593103 | Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial |
| Q37810816 | Progress towards a needle-free hepatitis B vaccine |
| Q38175504 | Selective hair therapy: bringing science to the fiction |
| Q36998403 | Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response. |
| Q43477258 | Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses |
| Q37848296 | Topical and mucosal liposomes for vaccine delivery. |
| Q34121001 | Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells |